Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) PT at $12.13

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been given a consensus rating of “Buy” by the six analysts that are presently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year target price among brokerages that have covered the stock in the last year is $12.13.

Several equities research analysts have weighed in on BIOX shares. Oppenheimer lowered their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, October 21st. Canaccord Genuity Group dropped their target price on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a report on Wednesday, November 13th.

Bioceres Crop Solutions Trading Down 1.0 %

BIOX stock opened at $6.91 on Tuesday. The company has a market capitalization of $433.33 million, a PE ratio of 345.67 and a beta of 0.56. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. Bioceres Crop Solutions has a 12 month low of $5.71 and a 12 month high of $14.05. The firm’s 50-day moving average is $6.56 and its 200 day moving average is $8.32.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The company had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. During the same period in the prior year, the firm posted ($0.07) EPS. On average, research analysts anticipate that Bioceres Crop Solutions will post 0.12 EPS for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of hedge funds have recently made changes to their positions in the stock. Stifel Financial Corp grew its stake in Bioceres Crop Solutions by 33.4% in the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after buying an additional 5,341 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after buying an additional 29,693 shares during the last quarter. Long Focus Capital Management LLC raised its stake in shares of Bioceres Crop Solutions by 19.9% during the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock worth $3,145,000 after acquiring an additional 46,647 shares in the last quarter. Finally, Fourth Sail Capital LP lifted its position in Bioceres Crop Solutions by 20.5% during the second quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock valued at $21,992,000 after acquiring an additional 334,195 shares during the last quarter. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.